You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CEL

Showing 26 - 50 of 255
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Aggressive B-cell Lymphomas, Refractory B-Cell Non-Hodgkin Lymphoma, Aggressive B-cell NHL Trial in Boston

Not yet recruiting
  • Refractory Aggressive B-cell Lymphomas
  • +12 more
  • Boston, Massachusetts
  • +1 more
Oct 13, 2022

NHL, DLBCL - Diffuse Large B Cell Lymphoma Trial in Netherlands (ARI-0001, Axi-cel)

Recruiting
  • NHL
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Amsterdam, Netherlands
  • +6 more
Nov 30, 2022

Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Nashville (CTX001)

Recruiting
  • Beta-Thalassemia
  • +4 more
  • CTX001
  • Nashville, Tennessee
  • +5 more
Feb 2, 2023

Sickle Cell Disease, Hydroxyurea Failure, Hydroxyurea Intolerance Trial in Nashville (CTX001)

Recruiting
  • Sickle Cell Disease
  • +4 more
  • CTX001
  • Philadelphia, Pennsylvania
  • +3 more
Jan 24, 2023

Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)

Not yet recruiting
  • Beta-Thalassemia
  • +6 more
  • CTX001
  • (no location specified)
Jul 26, 2022

COVID-19, Coronavirus Infection Trial in Bulgaria, Israel, Romania (Piclidenoson, Placebo)

Completed
  • COVID-19
  • Coronavirus Infection
  • Sofia, Bulgaria
  • +5 more
Apr 21, 2022

CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

Recruiting
  • Central Nervous System Tumor
  • +10 more
  • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

Relapsed/Refractory Follicular Lymphoma Trial in Nashville (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine)

Recruiting
  • Relapsed/Refractory Follicular Lymphoma
  • Axicabtagene Ciloleucel
  • +8 more
  • Denver, Colorado
  • +6 more
Dec 2, 2022

Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug

Enrolling by invitation
  • Cerebral Adrenoleukodystrophy (CALD)
  • +2 more
  • Lenti-D
  • Los Angeles, California
  • +10 more
Nov 4, 2022

Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)

Active, not recruiting
  • Beta-Thalassemia
  • +4 more
  • CTX001
  • Stanford, California
  • +11 more
Nov 30, 2022

Multiple Myeloma Trial in Worldwide (Cilta-cel)

Recruiting
  • Multiple Myeloma
  • Phoenix, Arizona
  • +30 more
Aug 11, 2022

Cerebral Adrenoleukodystrophy (CALD) Trial in Worldwide (Lenti-D)

Active, not recruiting
  • Cerebral Adrenoleukodystrophy (CALD)
  • Lenti-D
  • Palo Alto, California
  • +7 more
Mar 22, 2022

Multiple Myeloma Trial in United States (Cilta-cel, Lymphodepleting Therapy (Cyclophosphamide and Fludarabine))

Recruiting
  • Multiple Myeloma
  • Cilta-cel
  • Lymphodepleting Therapy (Cyclophosphamide and Fludarabine)
  • Duarte, California
  • +23 more
Aug 1, 2022

COVID19 Pneumonia Trial in Romania (NuSepin® 0.1 mg, NuSepin® 0.2 mg, Placebo)

Completed
  • COVID19 Pneumonia
  • NuSepin® 0.1 mg
  • +2 more
  • Cluj-Napoca, Romania
  • +4 more
Jan 27, 2022

Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)

Available
  • Epstein-Barr Virus (EBV) Infections
  • +11 more
  • tabelecleucel
  • (no location specified)
Feb 15, 2022

Sickle Cell Disease Trial in United States (bb1111)

Recruiting
  • Sickle Cell Disease
  • bb1111
  • Birmingham, Alabama
  • +8 more
Jul 15, 2022

A Long-term Follow-up Study in Subjects Who Received CTX001

Enrolling by invitation
  • Beta-Thalassemia
  • +6 more
  • CTX001
  • New York, New York
  • +12 more
Nov 18, 2022

Type 2 Diabetes, High Blood Pressure, Arthritis Trial in Albany (Metformin, Val, Cel and Met XR Low, Val, Cel and Met XR High)

Not yet recruiting
  • Type 2 Diabetes
  • +3 more
  • Albany, New York
    Albany Medical College
Dec 28, 2020

Skin Disorders Trial in Newport Beach (Topical combination therapy)

Completed
Has Results
  • Skin Disorders
  • Topical combination therapy
  • Newport Beach, California
    Dr. George Taylor
Oct 15, 2020

Selected Factors on Cardiovascular System in Chronic Kidney

Completed
  • Atherosclerosis of Artery
  • +4 more
  • laboratory parameters - complete blood count
  • +23 more
  • Poznań, Poland
    Poznan University of Medical Sciences
Jan 25, 2022

Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Richter Syndrome Trial

Not yet recruiting
  • Recurrent Transformed Chronic Lymphocytic Leukemia
  • +2 more
  • Biopsy
  • +10 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Relapsed/Refractory Large B-Cell Lymphoma Trial in Beijing, Hangzhou (Prizloncabtagene autoleucel)

Recruiting
  • Relapsed/Refractory Large B-Cell Lymphoma
  • Prizloncabtagene autoleucel
  • Beijing, China
  • +1 more
Mar 24, 2023

Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Transformed Chronic

Not yet recruiting
  • Recurrent Transformed Chronic Lymphocytic Leukemia
  • +7 more
  • Biospecimen Collection
  • +9 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 15, 2023

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • Transformed Lymphoma
  • Handgrip strength test
  • +9 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 12, 2023

Multiple Myeloma Trial in United States (bb2121, Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +3 more
  • Scottsdale, Arizona
  • +19 more
Jul 7, 2022